Education
About Us
Working with TipRanks
Follow Us
Liquidia Technologies Inc (LQDA)
NASDAQ:LQDA
LQDA Stock Chart & Stats
$29.87
<$0.01(<0.01%)
At close: 4:00 PM EST
$29.87
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$10.37 - $30.88
Previous CloseN/A
Volume97.81K
Average Volume (3M)2.49M
Market Cap
$2.60B
Enterprise Value$2.00B
Total Cash (Recent Filing)$157.50M
Total Debt (Recent Filing)$199.18M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Mar 12, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding86,995,480
10 Day Avg. Volume2,370,530
30 Day Avg. Volume2,485,726
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)11.98
Price to Sales (P/S)66.13
P/FCF Ratio-9.41
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue28.97
Enterprise Value/Gross Profit32.40
Enterprise Value/Ebitda-20.36
Forecast
1Y Price Target
$47.50Price Target Upside59.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-0.77
Revenue Forecast (FY)$141.74M
Bulls Say, Bears Say
Bulls Say
Financial ResultsLQDA posted a strong Q3 that beat consensus and analyst's bullish expectations.
Market PerformanceYutrepia's growth continues to exceed expectations with profitability achieved in the first full quarter of its launch.
Product InnovationL606 can extend Yutrepia’s commercial momentum in PAH and PH-ILD by adding a second clinically differentiated asset within the same treatment landscape.
Bears Say
Financial StabilityYears of cash left is approximately 1.1, indicating limited financial runway.
Investor SentimentThe stock traded down due to investor perceptions that management sounded more bearish on the '327 litigation.
Legal RisksThere are risks associated with the potential outcomes of the '327 patent infringement case, which could impact future operations.
Liquidia Technologies News
LQDA FAQ
What was Liquidia Technologies Inc’s price range in the past 12 months?
Liquidia Technologies Inc lowest stock price was $10.37 and its highest was $30.88 in the past 12 months.
What is Liquidia Technologies Inc’s market cap?
Liquidia Technologies Inc’s market cap is $2.60B.
When is Liquidia Technologies Inc’s upcoming earnings report date?
Liquidia Technologies Inc’s upcoming earnings report date is Mar 12, 2026 which is in 107 days.
How were Liquidia Technologies Inc’s earnings last quarter?
Liquidia Technologies Inc released its earnings results on Nov 03, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.389 by $0.349.
Is Liquidia Technologies Inc overvalued?
According to Wall Street analysts Liquidia Technologies Inc’s price is currently Undervalued.
Does Liquidia Technologies Inc pay dividends?
Liquidia Technologies Inc does not currently pay dividends.
What is Liquidia Technologies Inc’s EPS estimate?
Liquidia Technologies Inc’s EPS estimate is 0.21.
How many shares outstanding does Liquidia Technologies Inc have?
Liquidia Technologies Inc has 86,995,480 shares outstanding.
What happened to Liquidia Technologies Inc’s price movement after its last earnings report?
Liquidia Technologies Inc reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.389. Following the earnings report the stock price went up 3.53%.
Which hedge fund is a major shareholder of Liquidia Technologies Inc?
Currently, no hedge funds are holding shares in LQDA
Liquidia Technologies Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.50 (59.02% Upside)
$47.50 (59.02% Upside)
Blogger Sentiment
Bullish
LQDA Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $20.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 20.8%
Last 30 Days ▲ 38.1%
Last 30 Days ▲ 38.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
186.79%
12-Months-Change
Fundamentals
Return on Equity
-183.82%
Trailing 12-Months
Asset Growth
9.13%
Trailing 12-Months
Company Description
Liquidia Technologies Inc
Liquidia Technologies (LQDA) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for patients with serious diseases. The company utilizes its proprietary PRINT technology platform to design and manufacture nanoparticles that enable targeted delivery of therapeutics. Liquidia's core product candidates include LIQ861, a treatment for pulmonary arterial hypertension, and LIQ865, aimed at addressing various respiratory conditions.
LQDA Company Deck
LQDA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Liquidia has experienced a strong launch and financial performance with YUTREPIA, achieving significant prescription uptake and positive cash flow. However, the ongoing net loss and litigation uncertainty present challenges that could impact future performance.View all LQDA earnings summariesLQDA Stock 12 Month Forecast
Average Price Target
$47.50
▲(59.02% Upside)
Technical Analysis
Ocular Therapeutix
―
Adaptive Biotechnologies
―
Arcutis Biotherapeutics
―
Disc Medicine
―
Recursion Pharmaceuticals
―
Ownership Overview
22.64% Insiders
6.97% Mutual Funds
38.68% Other Institutional Investors
23.01% Public Companies and Individual Investors